(Q61918077)

English

Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

An Open Label, Multicenter Trial Assessing the Acceptability of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Patients With Type 2 Diabetes and Dyslipidemia (English)

0 references

0 references

0 references

March 2007

0 references

number of participants

29

0 references

research intervention

metformin

0 references

fenofibrate / pravastatin

0 references

clinical trial phase

phase III clinical trial

0 references

research subject recruitment status

completed

0 references

minimum age

20 year

0 references

maximum age

80 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00490178

0 references

(Q61918077)

Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)